Previous studies have demonstrated that CDK5 activity is increased in several different neurodegenerative diseases including AD, animal models of amyotrophic lateral sclerosis (ALS) and Niemann Pick type C (NPC) disease [61–63]. Here, CDK5 is linked to Alzheimer disease.